The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
HEPARIN INTERPHARMA (Interpharma Pty Ltd)
Product name
HEPARIN INTERPHARMA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
214 (255 working days)
Active ingredients
heparin sodium
Registration type
NCE/NBE
Indication
Prophylaxis and treatment of deep vein thrombosis for use in patients 18 years and older.